Previous close | 60.27 |
Open | 60.47 |
Bid | 59.42 x 1000 |
Ask | 62.00 x 800 |
Day's range | 60.14 - 61.77 |
52-week range | 40.72 - 64.03 |
Volume | |
Avg. volume | 4,059,193 |
Market cap | 44.381B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | 25.52 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.60 (1.02%) |
Ex-dividend date | 11 Aug 2022 |
1y target est | N/A |
Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the second quarter and six months ended June 30, 2022.
Corteva, Inc. (NYSE: CTVA) today announced its Board of Directors has authorized an increase of its common stock dividend of one cent ($0.01) to $0.15 cents per share, payable September 15, 2022, to the Company's shareholders of record on August 12, 2022 – representing an annualized increase of 7.4% over the Company's previous quarterly dividend.
Today, 2Blades and Corteva Agriscience announced they have reached a milestone in their collaboration to develop a transgene for Asian Soybean Rust (ASR) resistance with successful field trials of Latin American soybean varieties containing the new ASR transgene. This achievement marks an important point in the research collaboration between the two organizations, which seeks to develop durable resistance and minimize grower losses due to the plant pathogen.